IMIDE/AMIDE ETHERS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF DECREASE OF FNOK LEVEL IN MAMMALIAN Russian patent published in 2001 - IPC

Abstract RU 2164514 C2

FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes imide/amide ethers of the formula (I) where R1 means unsubstituted or substituted linear, branched or cyclic C1-C12-alkyl, substituted or unsubstituted phenyl; R2 means H, C1-C8-alkyl; R3 means ethylene, vinylene, branched alkylene and others; R4 means -CX- or -CH2-; X means O or S; n = 0, 1, 2, 3. These compounds are used for decrease of FNOK level in mammalian. Invention describes also the pharmaceutical composition based on these compounds and method of FNOK level decrease in mammalian. EFFECT: broadened assortment of compounds used for effect on FNOK level in mammalian. 7 cl, 1 tbl, 28 ex

Similar patents RU2164514C2

Title Year Author Number
IMMUNOTHERAPEUTIC IMIDES/AMIDES AS INHIBITORS OF PHOSPHODI-ESTERASE-IV (PDE-IV) AND TUMOR NECROSIS FACTOR (TNF) 1997
  • Maller Dzhordzh U.
  • Shajr Mehri
  • Sterling Dejvid I.
RU2177471C2
SUBSTITUTED HYDROXAMIC ACIDS, PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF AND METHOD OF TNF (TUMOR NECROSIS FACTOR) α DECREASE 1998
  • Maller Dzhordzh V.
  • Man Khon-Vo
RU2199530C2
ARYLMETHOXY ISOINDOLIN DERIVATIVE, COMPOSITIONS INCLUDING THEREOF AND METHODS OF THEIR APPLICATION 2011
  • Man Khon-Vakh
  • Mjuller Dzhordzh V.
  • Rachelmen Aleksander
  • Khalil Ehkhab M.
  • Chehn' Rodzher Shehn'-Chu
  • Chzhan Vehjkhun
RU2567753C2
SUBSTITUTED AMIDES, METHOD OF DECREASE OF TNF LEVEL, METHOD OF INHIBITION OF TNF-ACTIVATED REPLICATION OF RETROVIRUSES AND PHARMACEUTICAL COMPOSITION 1995
  • Dzhordzh Mjuller
  • Meri Shir
  • Dehvid I. Stirling
RU2162078C2
ISOINDOLINE COMPOUNDS USED FOR TREATING CANCER 2009
  • Mjuller Dzhordzh V.
  • Rachelmen Aleksander L.
RU2527952C2
IMIDES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS OF INHIBITION OF ACTIVITY OF PHOSPHODIESTERASE, α, ФHO 1996
  • Maller Dzhordzh V.
  • Shajr Mehri
RU2174512C2
SUCCINIMIDE AND MALEIMIDE INHIBITORS OF CYTOKINS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS OF INHIBITION OF TUMOR NECROSIS α-FACTOR 1996
  • Dzhordzh V. Mjuller
  • Mehri Shajr
RU2176242C2
ARYLAMIDES, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF TNF-ACTIVATED RETROVIRUS REPLICATION 1995
  • Dzhordzh Mjuller
  • Mehri Shir
  • Dehvid I. Stirling
RU2162839C2
IMIDES AS TNF-ALPHA INHIBITORS 1994
  • Mjuller Dzhordzh V.
RU2174516C2
SUBSTITUTED AMIDES, METHOD OF DECREASE OF TUMOR NECROSIS FACTOR (TNF) LEVEL AND INHIBITION OF PHOSPHODIESTERASE ACTIVITY AND PHARMACEUTICAL COMPOSITION 1996
  • Mjuller Dzhordzh V.
  • Shajr Mehri
RU2196134C2

RU 2 164 514 C2

Authors

Dzhordzh Mjuller

Mehri Shir

Dehvid I. Stirling

Dates

2001-03-27Published

1995-11-20Filed